Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 152.00
-4.30 (-2.75%)
At close: May 5, 2026
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 5.41 billion as of May 6, 2026. Its market cap has decreased by -2.43% in one year.
Market Cap
5.41B
Enterprise Value
5.37B
Revenue
2.07B
Ranking
n/a
PE Ratio
19.42
Stock Price
152.00
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 5.41B, an increase of 37,673.10%. That is a compound annual growth rate of 27.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 5.31B | -5.82% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermenta Biotech | 8.79B |
| Bharat Parenterals | 8.61B |
| Anuh Pharma | 8.56B |
| Kopran | 7.83B |
| Sudarshan Pharma Industries | 7.46B |
| ZIM Laboratories | 4.99B |
| Jenburkt Pharmaceuticals | 4.74B |
| Amanta Healthcare | 4.73B |